HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation

TSX-V:HME • CA4236301020

Current stock price

2.7 CAD
+0.07 (+2.66%)
Last:

This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. HME.CA Profitability Analysis

1.1 Basic Checks

  • In the past year HME was profitable.
  • HME had a positive operating cash flow in the past year.
  • Of the past 5 years HME 4 years were profitable.
  • HME had a positive operating cash flow in 4 of the past 5 years.
HME.CA Yearly Net Income VS EBIT VS OCF VS FCFHME.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • With an excellent Return On Assets value of 24.66%, HME belongs to the best of the industry, outperforming 98.06% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 38.33%, HME belongs to the top of the industry, outperforming 99.03% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 31.98%, HME belongs to the top of the industry, outperforming 99.51% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.84%.
  • The 3 year average ROIC (38.31%) for HME is well above the current ROIC(31.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 24.66%
ROE 38.33%
ROIC 31.98%
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
HME.CA Yearly ROA, ROE, ROICHME.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • HME's Profit Margin of 30.81% is amongst the best of the industry. HME outperforms 94.66% of its industry peers.
  • In the last couple of years the Profit Margin of HME has grown nicely.
  • HME has a Operating Margin of 42.73%. This is amongst the best in the industry. HME outperforms 92.23% of its industry peers.
  • HME's Operating Margin has improved in the last couple of years.
  • HME has a Gross Margin of 60.82%. This is in the better half of the industry: HME outperforms 78.16% of its industry peers.
  • In the last couple of years the Gross Margin of HME has remained more or less at the same level.
Industry RankSector Rank
OM 42.73%
PM (TTM) 30.81%
GM 60.82%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
HME.CA Yearly Profit, Operating, Gross MarginsHME.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. HME.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HME is creating value.
  • There is no outstanding debt for HME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HME.CA Yearly Shares OutstandingHME.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HME.CA Yearly Total Debt VS Total AssetsHME.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 5.73 indicates that HME is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.73, HME belongs to the top of the industry, outperforming 84.95% of the companies in the same industry.
  • HME has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
  • HME has a Debt to FCF ratio of 0.07. This is amongst the best in the industry. HME outperforms 96.60% of its industry peers.
  • HME has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of HME (0.03) is better than 75.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.07
Altman-Z 5.73
ROIC/WACC3.94
WACC8.11%
HME.CA Yearly LT Debt VS Equity VS FCFHME.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • HME has a Current Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
  • HME has a Current ratio of 1.41. This is in the better half of the industry: HME outperforms 68.93% of its industry peers.
  • A Quick Ratio of 1.41 indicates that HME should not have too much problems paying its short term obligations.
  • The Quick ratio of HME (1.41) is better than 69.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
HME.CA Yearly Current Assets VS Current LiabilitesHME.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. HME.CA Growth Analysis

3.1 Past

  • The earnings per share for HME have decreased strongly by -15.15% in the last year.
EPS 1Y (TTM)-15.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.71%

3.2 Future

  • HME is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.11% yearly.
  • HME is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.33% yearly.
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A

3.3 Evolution

HME.CA Yearly Revenue VS EstimatesHME.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
HME.CA Yearly EPS VS EstimatesHME.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2022 2023 2024 2025 2026 2027 2028 0 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

7

4. HME.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • HME is valuated reasonably with a Price/Earnings ratio of 9.64.
  • Compared to the rest of the industry, the Price/Earnings ratio of HME indicates a somewhat cheap valuation: HME is cheaper than 78.64% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.95, HME is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 10.49, the valuation of HME can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, HME is valued a bit cheaper than the industry average as 75.24% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 38.68. HME is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.64
Fwd PE 10.49
HME.CA Price Earnings VS Forward Price EarningsHME.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • HME's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HME is cheaper than 90.78% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HME is valued cheaper than 97.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.83
EV/EBITDA 4.35
HME.CA Per share dataHME.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The excellent profitability rating of HME may justify a higher PE ratio.
  • HME's earnings are expected to decrease with -16.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. HME.CA Dividend Analysis

5.1 Amount

  • HME has a Yearly Dividend Yield of 3.62%. Purely for dividend investing, there may be better candidates out there.
  • HME's Dividend Yield is a higher than the industry average which is at 3.62.
  • Compared to an average S&P500 Dividend Yield of 1.81, HME pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.62%

5.2 History

  • HME has been paying a dividend for over 5 years, so it has already some track record.
  • HME has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
HME.CA Yearly Dividends per shareHME.CA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 60.59% of the earnings are spent on dividend by HME. This is not a sustainable payout ratio.
DP60.59%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
HME.CA Yearly Income VS Free CF VS DividendHME.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
HME.CA Dividend Payout.HME.CA Dividend Payout, showing the Payout Ratio.HME.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HME.CA Fundamentals: All Metrics, Ratios and Statistics

HEMISPHERE ENERGY CORP

TSX-V:HME (4/20/2026, 7:00:00 PM)

2.7

+0.07 (+2.66%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)04-15
Earnings (Next)05-20
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners10.46%
Ins Owner ChangeN/A
Market Cap254.61M
Revenue(TTM)N/A
Net Income(TTM)30.27M
Analysts84.44
Price Target2.96 (9.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.62%
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP60.59%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-14
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.91%
Min EPS beat(2)-2.91%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-2.91%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.87%
EPS beat(12)5
Avg EPS beat(12)1.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.89%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)0.35%
Revenue beat(12)7
Avg Revenue beat(12)-0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.73%
PT rev (3m)19.59%
EPS NQ rev (1m)20%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)3.57%
EPS NY rev (3m)5.45%
Revenue NQ rev (1m)2.45%
Revenue NQ rev (3m)2.29%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE 9.64
Fwd PE 10.49
P/S 2.59
P/FCF 5.83
P/OCF 4.58
P/B 3.22
P/tB 3.22
EV/EBITDA 4.35
EPS(TTM)0.28
EY10.37%
EPS(NY)0.26
Fwd EY9.54%
FCF(TTM)0.46
FCFY17.16%
OCF(TTM)0.59
OCFY21.83%
SpS1.04
BVpS0.84
TBVpS0.84
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.29676 (-14.93%)
Profitability
Industry RankSector Rank
ROA 24.66%
ROE 38.33%
ROCE 42.48%
ROIC 31.98%
ROICexc 43.34%
ROICexgc 43.34%
OM 42.73%
PM (TTM) 30.81%
GM 60.82%
FCFM 44.47%
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.07
Debt/EBITDA 0.04
Cap/Depr 105.19%
Cap/Sales 12.1%
Interest Coverage 250
Cash Conversion 104.31%
Profit Quality 144.34%
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 5.73
F-Score6
WACC8.11%
ROIC/WACC3.94
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.71%
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
EBIT growth 1Y-3.75%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y130.83%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y39.86%
OCF growth 3Y36.33%
OCF growth 5Y34.82%

HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to HME.CA.


What is the valuation status for HME stock?

ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.


What is the profitability of HME stock?

HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.


Can you provide the financial health for HME stock?

The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 7 / 10.


What is the earnings growth outlook for HEMISPHERE ENERGY CORP?

The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -8.04% in the next year.